Medicare Enrolled
Dr. Rajeev Shukla, MD
Internal Medicine · Lodi, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shukla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shukla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shukla
Dr. Rajeev Shukla is an internal medicine specialist in Lodi, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Shukla performed 4,025 Medicare services across 1,771 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shukla received a total of $16,873 from 56 pharmaceutical and/or device companies across 863 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shukla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in CA
$16,873 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,025
Medicare services
Top 7% in CA for internal medicine
1,771
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~212 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,386 | $88 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
576 | $62 | $200 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
459 | $10 | $41 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
336 | $1 | $11 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
327 | $1 | $12 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
213 | $33 | $40 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
212 | $31 | $55 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
66 | $32 | $60 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
65 | $48 | $124 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
55 | $5 | $13 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
39 | $132 | $250 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
36 | $75 | $200 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
32 | $45 | $145 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
31 | $218 | $550 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
28 | $11 | $50 |
| Annual intensive behavioral therapy for cardiovascular disease, 15 minutes A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually. |
28 | $26 | $40 |
| Annual alcohol misuse screening, 5 to 15 minutes | 27 | $19 | $40 |
| Annual depression screening | 27 | $19 | $40 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
24 | $10 | $23 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
21 | $2 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $74 | $300 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
18 | $167 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,873
Total received (2018-2024)
Avg $2,410/year across 7 years
Top 7% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
863
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,873 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,929
2023
$1,976
2022
$2,078
2021
$2,811
2020
$1,420
2019
$3,164
2018
$3,495
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$383
Lilly USA, LLC
$362
Corcept Therapeutics
$278
PFIZER INC.
$169
Boehringer Ingelheim Pharmaceuticals, Inc.
$163
GlaxoSmithKline, LLC.
$154
Otsuka America Pharmaceutical, Inc.
$122
ABBVIE INC.
$88
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$69
Novo Nordisk Inc
$67
Amgen Inc.
$39
Medtronic, Inc.
$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$17
Top 3 companies account for 53.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,277
AstraZeneca Pharmaceuticals LP
$1,681
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,423
Janssen Pharmaceuticals, Inc
$1,319
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,138
Lilly USA, LLC
$1,010
GlaxoSmithKline, LLC.
$972
Amgen Inc.
$627
Allergan Inc.
$587
AbbVie Inc.
$536
PFIZER INC.
$433
IDORSIA PHARMACEUTICALS US INC
$387
Esperion Therapeutics, Inc.
$345
Corcept Therapeutics
$312
ABBVIE INC.
$302
Bayer HealthCare Pharmaceuticals Inc.
$293
Teva Pharmaceuticals USA, Inc.
$282
Novartis Pharmaceuticals Corporation
$250
Amarin Pharma Inc.
$243
ARBOR PHARMACEUTICALS, INC.
$225
Otsuka America Pharmaceutical, Inc.
$219
E.R. Squibb & Sons, L.L.C.
$210
Biohaven Pharmaceuticals, Inc.
$167
Takeda Pharmaceuticals U.S.A., Inc.
$156
Ironwood Pharmaceuticals, Inc
$127
Amneal Pharmaceuticals LLC
$112
Bayer Healthcare Pharmaceuticals Inc.
$110
Arbor Pharmaceuticals, Inc.
$105
Merck Sharp & Dohme Corporation
$101
Radius Health, Inc.
$98
MEDACTA USA, INC.
$93
Avanir Pharmaceuticals, Inc.
$78
KCI USA, Inc
$75
Exact Sciences Corporation
$75
SANOFI-AVENTIS U.S. LLC
$47
Neurocrine Biosciences, Inc.
$45
Aytu BioScience, Inc
$43
Eisai Inc.
$35
NESTLE HEALTHCARE NUTRITION INC.
$27
Biogen, Inc.
$25
Xeris Pharmaceuticals, Inc.
$24
Ethicon US, LLC
$21
Bioventus LLC
$21
Biohaven Pharmaceutical Holding Company Ltd.
$20
Actelion Pharmaceuticals US, Inc.
$20
Dexcom, Inc.
$19
Medtronic, Inc.
$19
Astellas Pharma US Inc
$18
Abbott Laboratories
$18
Endo Pharmaceuticals Inc.
$17
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$17
DEXCOM, INC.
$16
Kowa Pharmaceuticals America, Inc.
$14
Allergan, Inc.
$13
IRONWOOD PHARMACEUTICALS, INC
$13
Boston Scientific Corporation
$12
Top 3 companies account for 31.9% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · AVEED · Aimovig · BREO · BREZTRI · BYDUREON · BYSTOLIC · CAPLYTA · CHANTIX · CREON · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · DUZALLO · Dayvigo · Dexcom G6 Transmitter · Durolane · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · Edarbyclor · FARXIGA · FREESTYLE LIBRE 2 · GENERAL PAIN MANAGEMENT · GMK SPHERE · GVOKE PFS · Horizant · INGREZZA · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LINZESS · LYRICA · Linzess · Livalo · MOUNJARO · Myrbetriq · NEXLETOL · NEXLIZET · NUEDEXTA · NURTEC ODT · Natesto · OFEV · ONGENTYS · OPSUMIT · Otezla · Ozempic · PAXLOVID · PRADAXA · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · RYTARY · Repatha · Rybelsus · SHINGRIX · SNAP · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · Tymlos · UBRELVY · VIBERZI · VIIBRYD · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · Xultophy 100/3.6 · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
208
Per 100K population
26.4
County median income
$88,531
Nearest hospital
ADVENTIST HEALTH LODI MEMORIAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shukla is a clinical cardiology specialist, with above-average Medicare volume (top 7% in CA), with low-engagement industry engagement in the top 7% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shukla experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Shukla performed 1,386 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shukla receive payments from pharmaceutical companies?
Yes. Dr. Shukla received a total of $16,873 from 56 companies across 863 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shukla's costs compare to other internal medicine physicians in Lodi?
Dr. Shukla's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shukla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Lodi
Browse internal medicine physicians in Lodi ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology